Myofibroblast-specific Msi2 knockout inhibits hepatocellular carcinoma progression in a mouse model. Qu C, He L, Yao N, Li J, et al. Hepatology 2021 Feb 20. doi: 10.1002/hep.31754.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Qu C, He L, Yao N, Li J, et al. Myofibroblast-specific Msi2 knockout inhibits hepatocellular carcinoma progression in a mouse model. Hepatology 2021 Feb 20. doi: 10.1002/hep.31754.
PMID: 33609283